This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1996 Dec 13:803:321-3.

doi: 10.1111/j.1749-6632.1996.tb26406.x.

Lowered phosphorylation of topoisomerase I is a direct reason for reduced sensitivity of L5178Y-S cells to camptothecin

K Staron¹, B Kowalska-Loth, I Szumiel

Affiliations

PMID: 8993529
DOI: 10.1111/j.1749-6632.1996.tb26406.x

Lowered phosphorylation of topoisomerase I is a direct reason for reduced sensitivity of L5178Y-S cells to camptothecin

K Staron et al. Ann N Y Acad Sci. 1996.

. 1996 Dec 13:803:321-3.

doi: 10.1111/j.1749-6632.1996.tb26406.x.

Authors

K Staron¹, B Kowalska-Loth, I Szumiel

Affiliation

¹ Institute of Biochemistry, Warsaw University, Poland.

PMID: 8993529
DOI: 10.1111/j.1749-6632.1996.tb26406.x

No abstract available

PubMed Disclaimer

Similar articles

Phosphorylation of topoisomerase I in L5178Y-S cells is associated with poly(ADP-ribose) metabolism.
Staron K, Kowalska-Loth B, Nieznanski K, Szumiel I. Staron K, et al. Carcinogenesis. 1996 Mar;17(3):383-7. doi: 10.1093/carcin/17.3.383. Carcinogenesis. 1996. PMID: 8631120
The sensitivity to DNA topoisomerase inhibitors in L5178Y lymphoma strains is not related to a primary defect of DNA topoisomerases.
Lanza A, Tornaletti S, Stefanini M, Evans HH, Ricanati M, Astaldi Ricotti GC, Pedrini AM. Lanza A, et al. Carcinogenesis. 1993 Sep;14(9):1759-63. doi: 10.1093/carcin/14.9.1759. Carcinogenesis. 1993. PMID: 8403196
Modulation of the effect of camptothecin in x-irradiated L5178Y-R and L5178Y-S cells by benzamide.
Gradzka I, Iwaneńko T, Kruszewski M, Szumiel I, Kapiszewska M, Lange CS, Afanasjev G. Gradzka I, et al. Radiat Environ Biophys. 1996 Aug;35(3):185-91. doi: 10.1007/s004110050029. Radiat Environ Biophys. 1996. PMID: 8880961
Camptothecin resistance related to drug-induced down-regulation of topoisomerase I and to steps occurring after the formation of protein-linked DNA breaks.
Murren JR, Beidler DR, Cheng YC. Murren JR, et al. Ann N Y Acad Sci. 1996 Dec 13;803:74-92. doi: 10.1111/j.1749-6632.1996.tb26378.x. Ann N Y Acad Sci. 1996. PMID: 8993502 Review. No abstract available.
Cellular resistance to camptothecins.
Pommier Y, Gupta M, Valenti M, Nieves-Neira W. Pommier Y, et al. Ann N Y Acad Sci. 1996 Dec 13;803:60-73. doi: 10.1111/j.1749-6632.1996.tb26377.x. Ann N Y Acad Sci. 1996. PMID: 8993501 Review. No abstract available.

See all similar articles

Cited by

Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines.
Bandyopadhyay K, Gjerset RA. Bandyopadhyay K, et al. Biochemistry. 2011 Feb 8;50(5):704-14. doi: 10.1021/bi101110e. Epub 2011 Jan 12. Biochemistry. 2011. PMID: 21182307 Free PMC article.
Decreased camptothecin sensitivity of the stem-cell-like fraction of Caco2 cells correlates with an altered phosphorylation pattern of topoisomerase I.
Roy A, Tesauro C, Frøhlich R, Hede MS, Nielsen MJ, Kjeldsen E, Bonven B, Stougaard M, Gromova I, Knudsen BR. Roy A, et al. PLoS One. 2014 Jun 24;9(6):e99628. doi: 10.1371/journal.pone.0099628. eCollection 2014. PLoS One. 2014. PMID: 24960044 Free PMC article.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley